about
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgeryStroke prevention in atrial fibrillation: latest clinical trials and guidelinesEmpiric pacemaker compared with a monitoring strategy in patients with syncope and bifascicular conduction block--rationale and design of the Syncope: Pacing or Recording in ThE Later Years (SPRITELY) study.Age-dependent effect of β-blockers in preventing vasovagal syncope.Treatment of neurally mediated reflex syncope.Gynecological and menstrual disorders in women with vasovagal syncope.Usefulness of the Calgary Syncope Symptom Score for the diagnosis of vasovagal syncope in the elderly.Nitroglycerine in HUTT - An explosion in Our Understanding of Unexplained Syncope?2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.Syncope and Driving.Syncope clinical management in the emergency department: a consensus from the first international workshop on syncope risk stratification in the emergency departmentRationale for the Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5).Fludrocortisone for the Prevention of Vasovagal Syncope: A Randomized, Placebo-Controlled Trial.Atrial fibrillation: the current epidemicTricuspid valve regurgitation following temporary or permanent endocardial lead insertion, and the impact of cardiac resynchronization therapy.Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and designUtility of the NavX® Electroanatomic Mapping System for Permanent Pacemaker Implantation in a Pregnant Patient with Chagas Disease.Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.Electrophysiological characteristics of Chagas diseaseGastroesophageal reflux and atrial fibrillation: is there any correlation?Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review.Stroke and ventricular arrhythmias.Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.Automatic implantable cardioverter defibrillator lead dislodgement resulting in sudden cardiac death: a case report.Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial.Snapshot of adult invasive cardiac electrophysiology in Canada: results of the web-based registry.Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.Temporal relationship between subclinical atrial fibrillation and embolic events.Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study.Catheter Ablation as First-Line Therapy for Atrial Fibrillation: Ready for Prime-Time?Effectiveness of Intraoral Chlorhexidine Protocols in the Prevention of Ventilator-Associated Pneumonia: Meta-Analysis and Systematic Review.Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.The Word Heart Federation Roadmap for Nonvalvular Atrial Fibrillation.Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.Cryptogenic stroke and underlying atrial fibrillation.
P50
Q24201618-CA6CE125-116C-4C60-9B4A-692AD628CC0AQ24628390-6C1A92B5-E220-4FAB-97CA-66F8E8034593Q33160946-2EB9495D-AC1E-4BEA-8C27-D1A7BDC66725Q33161749-D6301CE7-9D9C-4B7A-A8FF-310D95CDC5C9Q33162135-C46BA67A-16C8-46A4-99A1-AFB1A5B892FCQ33162461-F471E68A-56B9-4BC2-86EE-B9E56BFF3784Q33162503-B42B4C7E-88F3-4F36-9C4D-C1FE3D2D64F9Q33163764-D67A9270-F771-41BF-B64F-3FCB81E8B784Q33165740-B71521C8-6462-4ADE-BE50-218D50E4F036Q33165942-11C548A6-D6E3-4D05-8A3F-74ADA6CDEF48Q33166081-BB3BAA4D-F138-455C-BFF3-8E1E23736EA9Q33166956-94DF9B12-87E3-4BA3-BD99-E637C3493BABQ33167359-F45B365C-2547-4F92-9A63-55B7201EA2EEQ33766896-65B88697-20AC-4EF9-B7CA-EE3A3627B6B1Q35062429-BADFF9DC-08C9-4CFC-A631-8E3808A857F4Q35114499-976E6C0E-8F84-4F20-B055-3E98BDFA083DQ36249613-1945BEAB-C334-46AE-9516-101C09CBD83EQ36515915-DC1156C9-5B2C-425E-B1DD-4BB33B9C172CQ36521252-5CCA61E8-AC0B-492C-A372-F28B49447EE8Q36594611-98557214-BC54-4CDC-865D-4F3FDDDC01FEQ36931388-883CDF72-2EDA-44FD-9D4F-C31AD8F0FF3EQ37990617-E4FECEB4-5DE4-41D3-B115-1E05D5D242FBQ38056336-58F93554-E243-49D3-8292-3336614112F3Q38100436-859643A7-077B-4633-AD94-5667BBD6996EQ38133053-2624B917-272D-43C6-8FC1-CCCCC3AFAE86Q38274280-424EEAE9-9C81-44F0-909C-615EABE5B42EQ38397292-9507BC59-4162-4E01-B991-D656B28E2767Q38398307-2845BA79-725C-44CF-9B7F-8C850B7311BFQ38425293-03EFAE4F-E8B3-4D1C-9874-FA9DA1A144D5Q38434320-DC051AEA-DA84-4FB2-812E-645D4B127B68Q38435943-B63E4BDB-BB35-4C6E-9B51-EE59E9A5359CQ38459074-1A142289-5DAE-44E6-9666-0D82AB945DA7Q38864989-1E79847D-2E5D-4AA0-881E-0D9BB364D1E1Q38923293-53A118C1-222F-4855-8B6C-B59AD8E275BFQ38995504-C4E7B9A6-8F0F-4159-9FAC-CE14355DDD82Q39015608-FB45B94F-B210-4F73-B392-76794B8E5A31Q39197308-C40B4C6B-5C08-4365-8778-1CD3D5D0ADFEQ39269371-D34F64E3-A0DF-4087-9380-85A792DE8996Q39269382-6EDA95FB-B328-4EDE-8B97-5ED27440044EQ40202915-BD4A1D2F-9804-45DF-8D43-1C5CC6BADDF2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlos A Morillo
@ast
Carlos A Morillo
@en
Carlos A Morillo
@es
Carlos A Morillo
@nl
Carlos A Morillo
@sl
type
label
Carlos A Morillo
@ast
Carlos A Morillo
@en
Carlos A Morillo
@es
Carlos A Morillo
@nl
Carlos A Morillo
@sl
prefLabel
Carlos A Morillo
@ast
Carlos A Morillo
@en
Carlos A Morillo
@es
Carlos A Morillo
@nl
Carlos A Morillo
@sl
P108
P106
P21
P31
P496
0000-0002-8739-2099
P569
2000-01-01T00:00:00Z